Peripheral Artery Disease (PAD)​

We are conducting an FDA-approved clinical study of one’s own fat-derived stem cells to help forestall the need for amputation in patients with severely compromised blood flow to the leg who have been told that they would otherwise require an amputation. We look forward to learning the outcomes of this approach over the next years, and are actively searching for patients interested in participating in this study.